Vincerx Pharma Q1 EPS $(0.58) Misses $(0.29) Estimate

Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.29) by 100 percent. This is a 14.71 percent increase over losses of $(0.6

Benzinga15:38

Vincerx Pharma | 10-Q: Quarterly report

SEC announcement15:30 · Announcements

Vincerx Pharma: Recent Financing Provides Expected Cash Runway Through 2024 >VINC

Vincerx Pharma: Recent Financing Provides Expected Cash Runway Through 2024 >VINC

Dow Jones15:27

Vincerx Pharma 1Q Loss/Shr 58c >VINC

Vincerx Pharma 1Q Loss/Shr 58c >VINC

Dow Jones15:26

Press Release: Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Vincerx Pharma, Inc. (Nasdaq: VINC), today reported financial results for the first quarter of 2024 and provided a corporate update.

Dow Jones15:15

Vincerx Pharma Shares Are Trading Higher, Reversing From Earlier Weakness After the Company Announced a Proposed Underwritten Public Offering of Common Stock and Warrants.

Vincerx Pharma Shares Are Trading Higher, Reversing From Earlier Weakness After the Company Announced a Proposed Underwritten Public Offering of Common Stock and Warrants.

BenzingaApr 29 10:04